Lifevantage Corporation (LFVN) - Net Assets
Based on the latest financial reports, Lifevantage Corporation (LFVN) has net assets worth $33.34 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($62.13 Million) and total liabilities ($28.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Lifevantage Corporation (LFVN) tangible net worth to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $33.34 Million |
| % of Total Assets | 53.66% |
| Annual Growth Rate | 22.09% |
| 5-Year Change | -5.88% |
| 10-Year Change | 185.56% |
| Growth Volatility | 9319.53 |
Lifevantage Corporation - Net Assets Trend (1997–2025)
This chart illustrates how Lifevantage Corporation's net assets have evolved over time, based on quarterly financial data. See LFVN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Lifevantage Corporation (1997–2025)
The table below shows the annual net assets of Lifevantage Corporation from 1997 to 2025. For live valuation and market cap data, see LFVN market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $34.64 Million | +33.28% |
| 2024-06-30 | $25.99 Million | -24.99% |
| 2023-06-30 | $34.65 Million | +9.94% |
| 2022-06-30 | $31.52 Million | -14.37% |
| 2021-06-30 | $36.81 Million | +10.68% |
| 2020-06-30 | $33.25 Million | +22.26% |
| 2019-06-30 | $27.20 Million | +23.93% |
| 2018-06-30 | $21.95 Million | +51.08% |
| 2017-06-30 | $14.53 Million | +19.75% |
| 2016-06-30 | $12.13 Million | +264.84% |
| 2015-06-30 | $3.33 Million | -16.67% |
| 2014-06-30 | $3.99 Million | -88.25% |
| 2013-06-30 | $33.95 Million | +20.02% |
| 2012-06-30 | $28.28 Million | +235.92% |
| 2011-06-30 | $-20.81 Million | -28.64% |
| 2010-06-30 | $-16.17 Million | -135.99% |
| 2009-06-30 | $-6.85 Million | -316.27% |
| 2008-06-30 | $3.17 Million | +16.80% |
| 2007-06-30 | $2.71 Million | -67.25% |
| 2006-06-30 | $8.28 Million | -24.53% |
| 2005-06-30 | $10.98 Million | +46633.27% |
| 2004-06-30 | $23.49K | -20.97% |
| 2003-06-30 | $29.72K | -22.11% |
| 2002-06-30 | $38.16K | +224.99% |
| 2000-06-30 | $11.74K | -56.42% |
| 1999-06-30 | $26.95K | -74.50% |
| 1998-06-30 | $105.66K | -18.53% |
| 1997-06-30 | $129.70K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lifevantage Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10414700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.00K | 0.00% |
| Other Comprehensive Income | $-1.18 Million | -3.39% |
| Other Components | $139.96 Million | 404.04% |
| Total Equity | $34.64 Million | 100.00% |
Lifevantage Corporation Competitors by Market Cap
The table below lists competitors of Lifevantage Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gedeon Richter PLC
LSE:0QFP
|
$67.37 Million |
|
Nyquest Technology Co Ltd
TWO:6494
|
$67.41 Million |
|
Anam Electroni
KO:008700
|
$67.42 Million |
|
Chumporn Palm Oil Industry Public Company Limited
BK:CPI
|
$67.45 Million |
|
Making Science Group S.A.
MC:MAKS
|
$67.33 Million |
|
Focus Lighting and Fixtures Limited
NSE:FOCUS
|
$67.32 Million |
|
Cytogen Inc
KQ:217330
|
$67.30 Million |
|
Boustead Heavy Industries
KLSE:8133
|
$67.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lifevantage Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 25,991,000 to 34,641,000, a change of 8,650,000 (33.3%).
- Net income of 9,805,000 contributed positively to equity growth.
- Dividend payments of 2,067,000 reduced retained earnings.
- Share repurchases of 5,811,000 reduced equity.
- Other comprehensive income increased equity by 741,000.
- Other factors increased equity by 5,982,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $9.80 Million | +28.3% |
| Dividends Paid | $2.07 Million | -5.97% |
| Share Repurchases | $5.81 Million | -16.77% |
| Other Comprehensive Income | $741.00K | +2.14% |
| Other Changes | $5.98 Million | +17.27% |
| Total Change | $- | 33.28% |
Book Value vs Market Value Analysis
This analysis compares Lifevantage Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.27x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.56x to 2.27x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-06-30 | $1.09 | $6.06 | x |
| 1998-06-30 | $0.89 | $6.06 | x |
| 1999-06-30 | $0.23 | $6.06 | x |
| 2000-06-30 | $0.10 | $6.06 | x |
| 2001-06-30 | $0.34 | $6.06 | x |
| 2002-06-30 | $0.28 | $6.06 | x |
| 2003-06-30 | $0.21 | $6.06 | x |
| 2004-06-30 | $0.17 | $6.06 | x |
| 2005-06-30 | $4.37 | $6.06 | x |
| 2006-06-30 | $2.62 | $6.06 | x |
| 2007-06-30 | $0.85 | $6.06 | x |
| 2008-06-30 | $0.98 | $6.06 | x |
| 2009-06-30 | $-1.19 | $6.06 | x |
| 2010-06-30 | $-1.97 | $6.06 | x |
| 2011-06-30 | $-1.99 | $6.06 | x |
| 2012-06-30 | $1.67 | $6.06 | x |
| 2013-06-30 | $1.93 | $6.06 | x |
| 2014-06-30 | $0.25 | $6.06 | x |
| 2015-06-30 | $0.23 | $6.06 | x |
| 2016-06-30 | $0.83 | $6.06 | x |
| 2017-06-30 | $1.03 | $6.06 | x |
| 2018-06-30 | $1.55 | $6.06 | x |
| 2019-06-30 | $1.82 | $6.06 | x |
| 2020-06-30 | $2.28 | $6.06 | x |
| 2021-06-30 | $2.58 | $6.06 | x |
| 2022-06-30 | $2.41 | $6.06 | x |
| 2023-06-30 | $2.76 | $6.06 | x |
| 2024-06-30 | $2.00 | $6.06 | x |
| 2025-06-30 | $2.67 | $6.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lifevantage Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 28.30%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.29%
- • Asset Turnover: 3.18x
- • Equity Multiplier: 2.08x
- Recent ROE (28.30%) is above the historical average (-4.37%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -15.30% | 0.00% | 0.00x | 2.38x | $-32.81K |
| 1998 | -22.75% | 0.00% | 0.00x | 2.92x | $-34.60K |
| 1999 | -292.10% | 0.00% | 0.00x | 6.80x | $-81.41K |
| 2000 | -129.47% | -1520400.00% | 0.00x | 3.04x | $-16.38K |
| 2001 | -56.19% | -2473000.00% | 0.00x | 1.00x | $-29.13K |
| 2002 | -42.84% | 0.00% | 0.00x | 1.03x | $-20.17K |
| 2003 | -31.73% | 0.00% | 0.00x | 1.23x | $-12.40K |
| 2004 | -52.11% | 0.00% | 0.00x | 1.62x | $-14.59K |
| 2005 | -53.04% | -247.36% | 0.20x | 1.08x | $-6.92 Million |
| 2006 | -33.01% | -38.16% | 0.69x | 1.26x | $-3.56 Million |
| 2007 | -136.12% | -73.13% | 1.29x | 1.44x | $-3.96 Million |
| 2008 | -64.82% | -64.20% | 0.70x | 1.44x | $-2.37 Million |
| 2009 | 0.00% | -220.09% | 0.72x | 0.00x | $-8.43 Million |
| 2010 | 0.00% | -96.25% | 1.84x | 0.00x | $-9.43 Million |
| 2011 | 0.00% | -130.51% | 3.11x | 0.00x | $-48.71 Million |
| 2012 | 44.09% | 9.88% | 2.83x | 1.57x | $9.64 Million |
| 2013 | 22.41% | 3.65% | 3.75x | 1.63x | $4.21 Million |
| 2014 | 285.29% | 5.32% | 3.96x | 13.53x | $10.98 Million |
| 2015 | 210.14% | 3.67% | 4.66x | 12.29x | $6.65 Million |
| 2016 | 49.62% | 2.91% | 4.11x | 4.14x | $4.81 Million |
| 2017 | 11.07% | 0.81% | 4.41x | 3.11x | $155.30K |
| 2018 | 26.25% | 2.84% | 3.97x | 2.33x | $3.57 Million |
| 2019 | 27.31% | 3.29% | 4.09x | 2.03x | $4.71 Million |
| 2020 | 34.73% | 4.96% | 3.96x | 1.77x | $8.22 Million |
| 2021 | 35.03% | 5.86% | 2.80x | 2.14x | $9.21 Million |
| 2022 | 9.90% | 1.51% | 2.92x | 2.24x | $-31.60K |
| 2023 | 7.33% | 1.19% | 3.23x | 1.91x | $-924.90K |
| 2024 | 11.30% | 1.47% | 3.32x | 2.32x | $337.90K |
| 2025 | 28.30% | 4.29% | 3.18x | 2.08x | $6.34 Million |
Industry Comparison
This section compares Lifevantage Corporation's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $121,177,784
- Average return on equity (ROE) among peers: -150.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lifevantage Corporation (LFVN) | $33.34 Million | -15.30% | 0.86x | $67.37 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $199.86 Million | -2.89% | 0.00x | $5.11 Million |
| Agape ATP Corporation Common Stock (ATPC) | $1.93 Million | -128.06% | 0.68x | $2.64 Million |
| B&G Foods Inc (BGS) | $174.63 Million | 10.21% | 3.85x | $313.60 Million |
| BioHarvest Sciences Inc. Common Stock (BHST) | $1.33 Million | -970.90% | 17.80x | $72.31 Million |
| BranchOut Food Inc. Common Stock (BOF) | $5.57 Million | -109.92% | 1.60x | $57.59 Million |
| Bellring Brands LLC (BRBR) | $-65.50 Million | 0.00% | 0.00x | $1.05 Billion |
| BRC Inc. (BRCC) | $49.50 Million | -5.96% | 3.59x | $152.11 Million |
| BRF SA ADR (BRFS) | $800.55 Million | -313.82% | 16.84x | $5.38 Billion |
| Bridgford Foods Corporation (BRID) | $44.60 Million | 14.80% | 0.47x | $61.63 Million |
| Borealis Foods Inc. (BRLS) | $-695.89K | 0.00% | 0.00x | $28.97 Million |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids… Read more